Table 2.
Treatment characteristics: Floxuridine (FUDR) was given with 90Y in some of our earlier patients. FUDR (5 mg/kg) was given just prior to administration of the 90Y microspheres.
| n (%) | Median | Range | |
|---|---|---|---|
| Total number of treatments | 90 | ||
| Patients with 1 treatment | 20 (39.2) | ||
| Patients with 2 treatments | 27 (52.9) | ||
| Patients with 4 treatments | 4 (7.8) | ||
| Radiation dose to target tissue per treatment (Gy) | 44.4 | 12.9–67.2 | |
| Radiation activity per treatment (GBq) | 0.89 | 0.16–2.20 | |
| FUDR with 90Y* | |||
| Yes | 17 (33.3) | ||
| No | 34 (66.7) | ||
| Lung shunt (%) | 3.3 | 0.4–11.5 | |
| Treatments terminated early due to embolic process | 40 (44.4) | ||
| Treatments with ≥80% of prescribed dose administered | 67 (74.4) |
*Those who had prior hepatic artery chemoinfusion separate from the time of 90Y administration are not included in this group.